Related Experiment Video
Updated: Sep 28, 2026

In Vivo Infection with Leishmania amazonensis to Evaluate Parasite Virulence in Mice
Published on: February 20, 2020
Seroconversion against Lutzomyia longipalpis saliva concurrent with the development of anti-Leishmania chagasi
Regis B Gomes1, Cláudia Brodskyn, Camila I de Oliveira
1Centro de Pesquisa Gonçalo Moniz, Fundação Oswaldo Cruz, and Faculdade de Medicina, Universidade Federal da Bahia, Salvador, Bahia, Brazil.
Abstract:
Antibody responses to salivary gland sonicate (SGS) from Lutzomyia longipalpis were investigated using serum samples from individuals living in an area where visceral leishmaniasis is endemic. Individuals were classified into 2 groups, according to the alteration of their responses to Leishmania chagasi antigen over the course of 6 months. Group 1 included children who experienced anti-L. chagasi seroconversion from negative to positive; group 2 included children who experienced delayed-type hypersensitivity (DTH) response to L. chagasi antigen conversion from negative to positive. Individuals who experienced seroconversion against L. chagasi antigens did not have increased anti-saliva antibody response, whereas those who developed a positive anti-L. chagasi DTH response had increased immunoglobulin (Ig) G, IgG1 and IgE anti-SGS antibody levels. Despite wide variation, serum samples from individuals in group 2 recognized more bands in SGS than did those from individuals in group 1. This simultaneous appearance of anti-saliva humoral response and anti-L. chagasi cell-mediated immunity supports the hypothesis that induction of immune response against SGS can facilitate induction of a protective response against leishmaniasis.
Related Concept Videos
Leishmaniasis
Antiprotozoal Agents
American Trypanosomiasis
Toxoplasmosis
Rabies
